Eric Dobmeier, Director at Atara Biotherapeutics, Inc. (ATRA), bought 893,650 shares at $0.23 ($206K) on 2023-11-10, disclosed to the SEC on 2023-11-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.23 | 446,825 | $103K | 50.0% |
| 2 | $0.23 | 446,825 | $103K | 50.0% |
| Total | $0.23 avg | 893,650 | $206K | 100% |
| Filing → |
| KDNY | SELL | 2023-02-01 | $993K | — | Filing → |
| KDNY | SELL | 2022-12-02 | $669K | — | Filing → |
| KDNY | BUY | 2022-05-27 | $65K | — | Filing → |